Strongbridge Biopharma plc — Form D

Strongbridge Biopharma plc of TREVOSE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-25. The offering totals $26.4M, of which $26.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ernest Tidemann Eichenberg IIIDirectorRadnor, PA
Espen Tidemann JorgensenDirectorRadnor, PA
H. Joseph ReiserDirectorVillanova, PA
Marten Tidemann SteenDirectorRadnor, PA
Alexander LindstromExecutive OfficerRadnor, PA
Matthew PaulsDirectorDurham, NC
Matthew PaulsExecutive OfficerDurham, NC
BRIAN DAVISExecutive OfficerGRAFTON, WI
A. Brian DavisExecutive OfficerWinston-Salem, NC
Robert LutzExecutive OfficerWoodinville, WA
Garheng H KongDirectorSeattle, WA
Stephen LongExecutive OfficerSan Francisco, CA
Joseph M MahadyDirectorWarrington, PA
Steve LongExecutive OfficerOklahoma City, OK
Stephen Brian LongExecutive OfficerTrevose, PA
Jeffrey W ShermanDirectorTrevose, PA
Marten H SteenDirectorTrevose, PA
A. Brian DavisExecutive OfficerTrevose, PA
Fredric Brian CohenExecutive OfficerTrevose, PA
Richard H KollenderDirectorTrevose, PA
Robert Brian LutzExecutive OfficerTrevose, PA
Hilde H SteinegerDirectorTrevose, PA
Ruth Thieroff-EkerdtExecutive OfficerNew York, NY
Eigil Stray SpetalenDirectorTrevose, PA
John H JohnsonDirectorBranchburg, NJ

Other filings by this issuer (3)

FiledFormOfferingSold
2016-12-30D$35.0M$35.0M
2015-09-14D$126.0M$126.0M
2015-07-17D$33.2M$33.2M

More